Articles related to ALZHEIMER'S/DEMENTIA

New research suggests that THC, when obtained from commercial dispensaries, may offer an effective treatment for neuropsychiatric symptoms in dementia patients, potentially reducing the need for antipsychotics.

The FDA’s approval of brexpiprazole for Alzheimer’s-related agitation has sparked a debate over its efficacy and safety, raising concerns that extend beyond this specific drug to the integrity of the regulatory process itself.

Explore the latest findings on the role of estrogen hormone therapy in Alzheimer’s disease prevention, focusing on the critical timing around menopause for potential intervention.

Discover how finger-tapping patterns could aid early Alzheimer’s diagnosis, offering a cost-effective and less intrusive screening method.

Discover the exciting research on the DR4 allele, a genetic variant that not only reduces the risk of Alzheimer’s but also offers protection against Parkinson’s disease. Explore the potential for targeted therapies and preventive measures.

A recent study found that patients who used proton pump inhibitors (PPIs) for more than 4.4 years had a 33% higher risk of developing dementia during the follow-up period.